Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Matthay

Showing results (121-130 of 316) with videos related to

Pageof 32
Sort By:
Journal of Digital Imaging|March 3, 2022
Incorporating Radiomics into Machine Learning Models to Predict Outcomes of NeuroblastomaGengbo Liu, Mini Poon, Matthew A Zapala, et al.
Medical and Pediatric Oncology|December 7, 2000
Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumorsJ R Park, J Slattery, T Gooley, et al.
British Journal of Cancer|April 29, 2010
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task ForceK K Matthay, B Shulkin, R Ladenstein, et al.
The Journal of Pediatrics|January 1, 1983
Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunizationD S Chudwin, D W Wara, K K Matthay, et al.
Pediatric Blood & Cancer|October 19, 2004
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastomaJames P Howard, John M Maris, Leslie S Kersun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastomaKenneth F Koral, John P Huberty, Bill Frame, et al.
Cancer Research|August 17, 2006
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastomaLouis Chesler, Chris Schlieve, David D Goldenberg, et al.
Cancer|August 30, 2000
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodularS Umehara, A Nakagawa, K K Matthay, et al.
Pediatric Blood & Cancer|May 12, 2026
Clinical and Biological Features of Response in Resistant Neuroblastoma to <sup>131</sup>I-Metaiodobenzylguanidine Radiotherapy in the Anti-GD2 Immunotherapy EraBenjamin J Lerman, Katherine K Matthay, Fabienne Hollinger, et al.
Journal of Pediatric Hematology/Oncology|August 26, 2000
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonusN L Antunes, Y Khakoo, K K Matthay, et al.
Pageof 32

Showing results (121-130 of 316) with videos related to

Sort By:
Pageof 32
Journal of Digital Imaging|March 3, 2022
Incorporating Radiomics into Machine Learning Models to Predict Outcomes of NeuroblastomaGengbo Liu, Mini Poon, Matthew A Zapala, et al.
Medical and Pediatric Oncology|December 7, 2000
Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumorsJ R Park, J Slattery, T Gooley, et al.
British Journal of Cancer|April 29, 2010
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task ForceK K Matthay, B Shulkin, R Ladenstein, et al.
The Journal of Pediatrics|January 1, 1983
Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunizationD S Chudwin, D W Wara, K K Matthay, et al.
Pediatric Blood & Cancer|October 19, 2004
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastomaJames P Howard, John M Maris, Leslie S Kersun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastomaKenneth F Koral, John P Huberty, Bill Frame, et al.
Cancer Research|August 17, 2006
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastomaLouis Chesler, Chris Schlieve, David D Goldenberg, et al.
Cancer|August 30, 2000
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodularS Umehara, A Nakagawa, K K Matthay, et al.
Pediatric Blood & Cancer|May 12, 2026
Clinical and Biological Features of Response in Resistant Neuroblastoma to <sup>131</sup>I-Metaiodobenzylguanidine Radiotherapy in the Anti-GD2 Immunotherapy EraBenjamin J Lerman, Katherine K Matthay, Fabienne Hollinger, et al.
Journal of Pediatric Hematology/Oncology|August 26, 2000
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonusN L Antunes, Y Khakoo, K K Matthay, et al.
Pageof 32